Otolaryngology · Alhambra, CA
NPI
1619190378
Since 2007
Specialty
Otolaryngology
Code 207Y00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
103 N Garfield Ave, Ste G
Alhambra, CA, 91801
Phone (626) 576-2352
Groups this clinician bills Medicare through
Medicare paid, 2024
$248K
2,893 services
Medicare patients, 2024
1,261
Average age 76
Drug cost, 2024
$209K
4,650 prescriptions
Company payments, 2025
$685
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Veling Tsai was code 99213 (office e&m - established), 712 times for 537 patients. In total Veling Tsai billed 2,893 services in 40 codes, and Medicare paid $248K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 712 | 537 | $75.02 | $53K |
| 92504 E&M - Miscellaneous | Office | 639 | 460 | $25.87 | $17K |
| 99214 Office E&M - Established | Office | 488 | 374 | $108.61 | $53K |
| 99203 Office E&M - New | Office | 428 | 428 | $81.37 | $35K |
| 99204 Office E&M - New | Office | 249 | 249 | $139.02 | $35K |
| 31575 Other Organ Systems | Office | 159 | 141 | $118.13 | $19K |
| 31231 Nasal/Sinus Endoscopy | Office | 117 | 105 | $173.65 | $20K |
| 99222 Hospital E&M - Initial | Facility | 18 | 17 | $116.24 | $2,092 |
By year: 2022 $184K for 2,191 services; 2023 $210K for 2,573 services; 2024 $248K for 2,893 services.
Medicare prescription drug claims, 2024
In 2024, the drug Veling Tsai prescribed most often to Medicare patients was Fluticasone Propionate, with 2,350 prescriptions and refills. In total Veling Tsai wrote 4,650 Medicare prescriptions that cost $209K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 2,350 | 3,216 | 731 | $23K |
| Fluocinolone Acetonide Oil Generic | 420 | 456 | 198 | $18K |
| Mometasone Furoate Generic | 237 | 345 | 86 | $16K |
| Omeprazole Generic | 215 | 412 | 92 | $1,642 |
| Azelastine Hcl Generic | 210 | 296 | 75 | $4,217 |
| Levocetirizine Dihydrochloride Generic | 210 | 255 | 70 | $1,342 |
| Ciprofloxacin-Dexamethasone Ciprofloxacin Hcl/Dexameth | 121 | 122 | 73 | $13K |
| Ipratropium Bromide Generic | 112 | 121 | 32 | $3,263 |
| Xhance Fluticasone Propionate | 105 | 107 | 18 | $64K |
| Ofloxacin Generic | 96 | 99 | 70 | $4,010 |
| Chlorhexidine Gluconate Generic | 96 | 96 | 45 | $493 |
| Triamcinolone Acetonide Generic | 65 | 72 | 46 | $980 |
| Pantoprazole Sodium Generic | 57 | 91 | 27 | $425 |
| Ibuprofen Generic | 46 | 46 | 41 | $161 |
| Famotidine Generic | 26 | 56 | 14 | $137 |
Brand drugs: 189 claims; generic drugs: 4,461 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Veling Tsai $685 ($685 in general payments such as food, travel and fees) from 7 companies. The largest payer was GlaxoSmithKline, LLC. with $293.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.